The strength of weight-bearing bones is similar in amenorrheic and eumenorrheic elite long-distance runners by Piasecki, J et al.
1 | P a g e  
 
The strength of weight-bearing bones is similar in amenorrheic and eumenorrheic elite 1 
long-distance runners  2 
 3 
Piasecki J.1* (MSc), Ireland A.1 (PhD), Piasecki M.1 (PhD), Cameron J.1 (MSc), McPhee J.S.1 4 
(PhD), Degens H.1,2 (PhD) 5 
 6 
1: School of Healthcare Science, Manchester Metropolitan University, Manchester, UK; 2: 7 
Institute of Sport Science and Innovations, Lithuanian Sports University, Kaunas, Lithuania 8 
 9 
Running Title: Amenorrhea effects on bone and muscle 10 
 11 
Manuscript word count: 6467 12 
 13 
ADDRESS FOR CORRESPONDENCE-  14 
J. Piasecki, School of Healthcare Science, MMU, John Dalton Building, Chester Street, 15 
Manchester, M1 5GD j.coulson@mmu.ac.uk, Telephone: 01612471207  16 
2 | P a g e  
 
Abstract (246 words) 17 
Background: Regular intense endurance exercise can lead to amenorrhea with possible 18 
adverse consequences for bone health.  19 
Objective: We compared whole-body and regional bone strength and skeletal muscle 20 
characteristics between amenorrheic (AA: n=14) and eumenorrheic (EA: n=15) elite adult 21 
female long distance runners and non-athletic controls (C: n=15).  22 
Study design and Participants: Participants completed three-day food diaries, dual energy x-23 
ray absorptiometry (DXA), magnetic resonance imaging (MRI), peripheral quantitative 24 
computed tomography (pQCT) and isometric maximal voluntary knee extension contraction 25 
(MVC). 26 
Results: Both athlete groups had a higher caloric intake than controls, with no significant 27 
difference between athlete groups. DXA revealed lower bone mineral density (BMD) at the 28 
trunk, rib, pelvis and lumbar spine in the AA than EA and C. pQCT showed greater bone size 29 
in the radius and tibia in EA and AA than C. The radius and tibia of AA had a larger endocortical 30 
circumference than C. Tibia bone mass and moments of inertia (Ix and Iy) were greater in AA 31 
and EA than C, whereas in the radius only the proximal Iy was larger in EA than C. Knee 32 
extensor MVC did not differ significantly between groups.  33 
Conclusions: Amenorrheic adult female elite long-distance runners had lower BMD in the 34 
trunk, lumbar spine, ribs and pelvis than eumenorrheic athletes and controls. The radius and 35 
tibia bone size and strength indicators were similar in amenorrheic and eumenorrheic 36 
athletes, suggesting that long bones of the limbs differ in their response to amenorrhea from 37 
bones in the trunk. 38 
Key words: eumennorheic, amenorrheic, athletes, endocortical, periosteal, muscle.  39 
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Introduction 40 
In elite endurance runners an appropriate balance between training, competition and 41 
recovery is important to maximise performance and prevent overtraining [1, 2]. When this 42 
balance is lost, injuries [2],such as stress fractures, caused by repeated stresses on the bone 43 
without appropriate recovery times can occur [1, 2]. 44 
 45 
The mechanostat theory states that bone adapts to increased mechanical loading (impact 46 
exercise) by increasing bone mass, size and strength [3-5] while reduced mechanical 47 
deformation decreases [3] bone mass, size and strength. In line with the mechanostat theory, 48 
indicators of bone strength are 5-30% higher in post-pubertal athletes than non-athletes [5-49 
9]. This suggests that physical activity is important for the development of high bone mass 50 
and strength, leading to 50-80% reduction in fracture risk [5]. 51 
 52 
Oestrogen limits bone resorption by reducing osteoclast activity [10]. This may explain why a 53 
low concentration of oestrogen, occurring in the absence of menses [11], has a negative effect 54 
on bone mineral density (BMD) [12] and is associated with a greater risk of bone stress injuries 55 
[13-15]. The prevalence of ‘athletic amenorrhea’ or menstrual irregularities amongst active 56 
young women can be as high as 60% [14]. The associated low oestrogen levels can diminish, 57 
or negate, benefits of regular exercise on bone [6, 16, 17].  58 
 59 
Amenorrhoea is one of three features of the ‘female athlete triad’ that was originally defined 60 
in 1997 as a simultaneous occurrence of amenorrhea, inadequate food intake and high 61 
training volume [18] that all have a negative impact on bone health. Most studies that 62 
considered the effects of amenorrhea on bone used dual-energy x-ray absorptiometry (DXA) 63 
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(e.g. [16, 17]).  Using DXA, higher BMD and strength indicators were found at the hip in 64 
eumenorrheic athletes than controls, while no such differences were seen between 65 
amenorrheic athletes and controls [16].  Something similar has been seen with high-66 
resolution peripheral quantitative computerised tomography (HR-pQCT) [6, 7]. However, HR-67 
pQCT does not give an indication of whole bone strength and cannot examine long bone shaft 68 
sites such as the tibia, which is particularly prone to stress fracture injury in athletes [19] but 69 
has received little attention in studies of amenorrheic athletes. Nevertheless, these studies 70 
suggest that there is a deficit in bone health in amenorrheic adolescent athletes and it is 71 
possible that symptoms are worse in adult elite level athletes due to a longer duration of 72 
amenorrhea than in adolescent athletes [20]. 73 
 74 
Reduced muscle mass, maximal force and quality (defined as maximal isometric force per unit 75 
muscle cross-sectional area) could be additional features of amenorrhea that impact on bone 76 
health due to a reduced mechanical stimulus to the bone [21].  It remains to be seen whether 77 
adult amenorrheic elite athletes have low muscle mass and/or quality of specific muscles 78 
associated with low strength in the bones these muscles act upon, and whether low bone 79 
strength is related to a low mass and/or quality of the muscles acting upon the corresponding 80 
bone. Such relationships can be examined using pQCT, along with imaging and dynamometry 81 
of muscle groups acting upon bone. 82 
 83 
The aim of the present study was to examine the interrelationship of muscle and bone 84 
characteristics in female, adult elite-level endurance athletes affected by amenorrhea. The 85 
primary hypothesis was that amenorrheic athletes have lower indicators of bone strength 86 
than eumenorrheic athletes and controls in body segments with lower direct exposure to 87 
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weight-bearing impacts, whilst these indicators will be preserved in weight-bearing bones of 88 
the amenorrheic athlete. 89 
 90 
 91 
Materials and Methods 92 
Participants 93 
Twenty-nine females, aged 17-42 years, were recruited after sending out a poster and 94 
participant information sheet to all athletes on an England Athletics email database. Of those 95 
that responded, only athletes that had represented their home country within the past two 96 
years in 1.5-10-km runs were eligible to participate and grouped according to their menstrual 97 
cycle history. All non-athletic controls were recruited from the local student population, 98 
performed less than 2 hours of physical activity per week and did not take part in athletic 99 
competitions. Participants were asked about the phase of menstrual cycle at the date of 100 
testing, use of oral contraceptive pills (OCP), any current medication, smoking habits, age of 101 
menarche and alcohol consumption. Based on self-reports, athletes were classified as 102 
amenorrheic (AA) if they had experienced an absence of menses for ≥ 12 months in a row 103 
within the past 12months. None of the athletes had oligomenorrhea (4-9 cycles per year). 104 
Athletes with regular menstrual cycles (> 12 in the past year) were classed as eumenorrheic 105 
(EA). Controls (C) had regular menstrual cycles, were recreationally active, but did not take 106 
part in competitive sports. As the study involves exposure to radiation during scanning any 107 
volunteers were excluded if they were pregnant or potentially pregnant. The Manchester 108 
Metropolitan University Ethics Committee approved the study and all participants gave 109 
written informed consent. Table 1 shows the participant characteristics.  110 
 111 
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Experimental Protocol 112 
Sporting history was obtained by questionnaire. Participants completed a food diary on three 113 
consecutive days, specifying food and drink consumption. This was analysed using nutritional 114 
analysis software (Diet Plan 6 software, Forestfield Ltd, Horsham, UK and Nutritics software, 115 
Nutritics, Dublin, Ireland). Six food diaries were excluded (two from controls, one from the EA 116 
and three from the AA group) due to incomplete details for accurate analysis. The age-graded 117 
performance (AGP) for the main event was calculated using the World Master Association’s 118 
Age-grading Calculator: 119 
http://www.howardgrubb.co.uk/athletics/wmalookup06.html. 120 
 121 
DXA 122 
Scans (GE Medical, Lunar Prodigy Advance, version encore 10.50.086) were taken to 123 
determine whole body, lumbar spine (L1-4) and hip bone mineral density (BMD), and body 124 
fat and lean mass percentage. Geometric properties of the femoral neck were estimated using 125 
the advanced hip analysis (AHA) software (GE Medical, Lunar Prodigy Advance, version encore 126 
10.50.086). This calculated the cross-sectional area (CSA), the cross-sectional moment of 127 
inertia (CSMI: an index of structural rigidity), the width of the neck and shaft of the femur and 128 
the bone strength index, a ratio of estimated compressive yield strength of the femoral neck 129 
to an expected compressive strength of a fall onto the greater trochanter [17]. In our 130 
laboratory, the coefficient of variation for body, hip and lumbar spine scans (n=8) is 0.67%, 131 
2.02% and 0.9%, respectively.   132 
 133 
pQCT 134 
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Scans were acquired at the non-dominant radius and dominant tibia with XCT-2000 and XCT-135 
3000 pQCT scanners (Stratec Medizintechnik GmbH, Pforzheim, Germany) according to the 136 
manufacturer’s protocols. Images obtained with the two scanners were cross-calibrated using 137 
functions derived from scans of different density regions within the same manufacturer-138 
provided phantom on each scanner. The dominant arm was identified as the writing arm, and 139 
in any cases of ambidexterity, the dominant arm was defined as the favoured arm when 140 
playing racquet sports. The non-dominant leg was defined as the leg that was preferentially 141 
used for hopping. Scans were taken at 4 and 60% of the radius length, and 4 and 66% of the 142 
tibia length, where 0% indicates the most distal part of the bones. Radius length was 143 
measured between the olecranon process and the radial styloid process. Tibia length was the 144 
distance between the palpated medial knee joint cleft and medial malleolus. 145 
 146 
Data were exported using the Automated Analysis Tools (Version 6.00). A peeling threshold 147 
of 180 mg·cm-3 was applied to the epiphyseal slice. At the diaphyseal sites, a threshold of 650 148 
mg·cm-3 was used to separate cortical bone.  149 
 150 
The following parameters examined in the 4% epiphyseal slice: total bone area (Ar.tot, mm2), 151 
total bone mineral content (vBMC.tot, mg·mm-1) and trabecular bone mineral density 152 
(vBMD.tb, mg·cm-3). iaphyseal parameters examined were: Ar.tot, vBMC.tot, cortical area 153 
(Ar.ct, mm2), cortical density (vBMD.ct, mg·cm-3), cortical thickness (Ct.Thder mm), periosteal 154 
(PsC, mm) and endocortical circumference (EcC, mm), antero-posterior (Ix) and mediolateral 155 
(Iy) moments of inertia representing bone bending stiffness. Cortical bone density values were 156 
corrected for the partial volume effect as described previously [22]. The coefficient of 157 
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variation of the pQCT measurements in our laboratory has been reported elsewhere [23] and 158 
was <0.5% for vBMC.tot, Ar.tot and Ar.ct.  159 
 160 
Magnetic Resonance Imaging (MRI) 161 
A 0.25-T G-scan MRI scanner (Esaote, Genova, Italy) was used to measure the volume of the 162 
quadriceps femoris and calf muscles. Serial cross sections (each 6.3 mm thick with a 50.4-mm 163 
inter-slice gap) were acquired from the lateral femoral condyle to the greater trochanter for 164 
the quadriceps and from the lateral femoral condyle to the lateral malleolus for the calf using 165 
a turbo 3-D T1 protocol [24]. Cross-sectional area was determined using Osirix software 166 
(Osirix medical imaging software, Atlanta, USA). The volumes of the muscle and femur bone 167 
were estimated as the integration of volume from each slice and inter-slice gap.  168 
 169 
Muscle strength measures 170 
Maximal voluntary isometric knee extensor torque of the quadriceps muscle was measured 171 
with a custom-built dynamometer [25]. Participants sat with hip and knee angles flexed at 172 
around 900 and straps fastened around the hip. Participants performed three maximum 173 
voluntary knee extension contractions, and the highest torque presented. Force was also 174 
expressed as force per quadriceps volume. 175 
 176 
Statistical Analysis 177 
Statistical analysis was performed on data normalised to object length or body height, to 178 
remove any variability caused by differences in these factors, with SPSSv19 (IBM, USA). Data 179 
was normally distributed as assessed using the Kolmogrov-Smirnov test.  A one-way ANOVA 180 
was used to assess any significant differences between control, amenorrheic and 181 
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eumenorrheic athletes. To test whether the radius and the tibia showed the same differences 182 
from control in amenorrheic and eumenorrheic athletes we performed a repeated-measures 183 
ANOVA with bone as within-factor bone, and group as between-factor on the data of the bone 184 
parameters normalised to the corresponding average control values for each bone. If a main 185 
group effect was found, a post-hoc test with Bonferroni correction was performed to 186 
determine which groups differed from each other. There were no group*bone interactions. 187 
Differences between groups were considered significant at p<0.05. All data are presented as 188 
mean ± standard error of the mean (SEM). All p-values shown in Tables 1-6 are those from 189 
post-hoc tests with Bonferroni correction. 190 
 191 
 192 
Results  193 
Participants 194 
There were no significant differences between groups in age or height (Table 1). Body mass 195 
and BMI were lower in the athletes than the C (p<0.05). Body mass of EA was 10% higher than 196 
that of AA (p=0.029). Lean mass of EA, but not that of AA, was higher than C (p=0.015) and 197 
both athletic groups had lower absolute and percentage fat mass than C (p<0.05). The age-198 
graded performance of EA and AA was within 15% of world record times, with no significant 199 
difference between the athlete groups. Onset of menarche was later in AA than C (p<0.05), 200 
with no significant differences between athlete groups or EA and C. Including the age of onset 201 
of menarche as a covariate did not change any statistical results and so was not included in 202 
final analysis (data not shown). 203 
 204 
Food Diaries 205 
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Total daily energy (kJ·day-1) intake was less in C than athlete groups (both p<0.05; C; 206 
6217±659, EA; 10567±880, AA; 9723±748).  207 
 208 
Muscle size and knee extensor strength 209 
Table 2 shows that there was no significant difference in forearm and tibia muscle cross-210 
sectional area, and calf and quadriceps muscle volume between any groups. Both athlete 211 
groups had greater maximal voluntary knee extension torque than C (p<0.045), (Table 2). 212 
Femur volume was higher in the athlete groups than C (p<0.05), but did not differ significantly 213 
between EA and AA (Table 2).  214 
 215 
 216 
DXA 217 
Total body, arms and hip BMD did not differ significantly between groups (Table 3). Trunk, 218 
rib, lumbar spine and pelvis BMD were lower in AA than EA and C (all p<0.05). Leg BMD was 219 
significantly greater in EA than C (p<0.05), with no significant difference between AA and C 220 
(Table 3). 221 
 222 
Hip structure of the femurs was similar for both athlete groups (Table 4). Cortical width of the 223 
femur shaft was greater in both athletes than C (p<0.05). There was no significant difference 224 
between any groups in the cortical width, cross-sectional area of the femur neck, bone 225 
strength index or cross-sectional moment of inertia. 226 
 227 
pQCT 228 
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Table 5 shows pQCT radius data. At the epiphyseal site the total bone area of the radius (Ar.tot) 229 
of both athlete groups was greater than C (p<0.05). Total bone mineral content (vBMC.tot), 230 
trabecular bone mineral density (vBMD.tb) and bone strength index of the radius epiphysis 231 
showed no significant differences between groups. 232 
 233 
At the diaphysis site of the radius, total area was larger in EA and AA than C(p<0.004), but 234 
there were no significant differences between groups in cortical bone mineral content and 235 
density (Table 5). 236 
 237 
The periosteal circumference was larger in the athletes than the C (p≤0.01; Figure 1A).  The 238 
moment of inertia was significantly greater in EA than C in the y plane, but there was no 239 
significant difference between any groups in the x plane (Table 5). 240 
 241 
Table 6 shows pQCT tibia data. Total bone mineral content for the epiphysis of the tibia was 242 
greater in EA than C (p<0.05), with no significant difference between athlete groups or AA and 243 
C. Trabecular BMD and total area of the tibia epiphysis was greater in both athlete groups than 244 
C (p<0.05), with no significant difference in bone strength index between groups. 245 
 246 
Total area and total bone mineral content at the tibia diaphysis were larger in the AA and EA 247 
than C (p<0.05). The trabecular BMD of the diaphysis was greater in C than AA (p=0.02) and 248 
EA (p<0.0005). The moment of inertia in the y- and x-plane at the tibia diaphysis was greater 249 
in the athletes than the C (p<0.05; Table 6). 250 
 251 
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For the diaphysis of both the radius and the tibia the cortical thickness did not differ 252 
significantly between groups (Figure 1B), but the cortical area was larger in EA than C 253 
(p=0.005; Figure 1C). The endocortical circumference (Figure 1D) was ~20% greater in AA than 254 
C (p=0.001), with no significant difference between C and EA, or EA and AA. These changes 255 
are illustrated in figure 2.  256 
 257 
Discussion 258 
The main observations of the study are that amenorrheic adult female elite long-distance 259 
runners have a lower bone mineral density in the trunk, lumbar spine, ribs and pelvis than 260 
eumenorrheic athletes and controls. In contrast, tibia cortical bone strength indicators were 261 
greater in both athlete groups than controls but no such difference was seen in the radius. 262 
This suggests that long bones differ in their response to amenorrhea from bones in the trunk. 263 
Similar to eumonerrheic athletes, the amenorrheic athletes had a larger and stronger tibia 264 
and femur than controls indicating that the bone response to regular loading is not 265 
attenuated by amenorrhea. Yet, it is unlikely that loading can normalise bone remodelling in 266 
amenorrheic athletes entirely as both the unloaded radius and the loaded tibia exhibited an 267 
increase in endocortical circumference. 268 
 269 
Study participants 270 
The long-distance runners in the present study had represented their country at international 271 
athletic events. The average age-graded performance for both athlete groups was 85%; for a 272 
26-year-old female this equates to 35 mins for 10 km and 2 hours 40 mins for a marathon. 273 
This confirmed that the recruited athletes were indeed elite athletes. The athletes were 274 
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classified as amenorrheic if they self-reported an absence of menses for at least 12 275 
consecutive months in a row. In addition, none of the athletes were oligomenorrheic, the 276 
average duration of amenorrhea in the AA was 5.5 years and the EA athletes were on average 277 
12 years eumenorrheic, indicating that the EA and AA athletes represented distinct groups. 278 
The self-reported method to characterise amenorrhea is preferred to measurement of sex 279 
hormones, which are subject to fluctuations during the menstrual cycle and diurnal variations 280 
[26]. 281 
  282 
Energy balance 283 
Persistent energy deficiency, occurring in up to 62% of elite female athletes, is considered an 284 
important cause of irregular or absent menstruation [18], both of which can lead to reduced 285 
bone health [20]. The common co-occurrence of amenorrhea and energy deficiency in 286 
athletes has made it difficult to disentangle the effects of amenorrhea and energy deficiency 287 
in previous studies [27]. In our study, the AA and EA reported similar total energy intake that 288 
exceeded that of the non-athletes by more than 30%, suggesting that energy deficit is unlikely 289 
to be the cause of bone differences between athletes and controls, or AA and EA, within our 290 
sample. 291 
 292 
Muscle mass and function 293 
According to the mechanostat theory [4], mechanical strain on bone, caused by muscle 294 
contraction, stimulates bone formation and increases bone strength [3, 4]. Effects of 295 
amenorrhea may thus be secondary to muscle weakness or a loss of muscle mass. We do not 296 
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think low muscle mass or weakness was a major consideration in our study because there 297 
were no significant differences in muscle mass and maximal strength between the 298 
eumenorrheic and amenorrheic athletes, although we did not determine the muscle forces 299 
during running and therefore cannot entirely rule out any differences between groups in the 300 
mechanical strain on bones during training. 301 
 302 
Non-weight-bearing bones  303 
The torso, lumbar spine, rib and hips of amenorrheic athletes had a lower BMD than those of 304 
the eumenorrheic athletes and controls. Bone area was also lower at these sites, and as a 305 
result amenorrheic athletes had large deficits in bone mineral content compared to the other 306 
two groups (data not shown). As these bones are not loaded during running, due to impact 307 
damping and limited direct contribution of the surrounding muscles to locomotion, it could 308 
be argued that the detrimental impact of amenorrhea on these bones is not compensated by 309 
the osteogenic effect of increased loading. Previous studies reported lower trabecular bone 310 
mineral density at the epiphysis of the radius in amenorrheic than eumenorrheic athletes and 311 
controls [6]. However in the current study it was observed that in contrast to the trunk 312 
skeleton, in the radius the bone mineral density was similar, and not less, in amenorrheic than 313 
eumenorrheic athletes and controls. Such a difference between bones in the response to 314 
amenorrhea has been observed previously; where bone mineral density was lower in the 315 
lumbar vertebrae, but not in the radius and the femur [28]. It has been suggested that the 316 
loss of bone mineral density in the lumbar vertebrae is due to loss of body mass rather than 317 
amenorrhea per se [29]. This indeed corresponds with the lower body mass of the 318 
amenorrheic athletes, but is at odds with the similar bone mineral density in the trunk 319 
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skeleton of eumenorrheic athletes and controls despite the lower body mass of the athletes. 320 
Also, in the radius, a lower body mass does not explain the absence of a lower bone mineral 321 
density in the the amenorrheic athletes. We speculate that the best explanation for the lower 322 
bone mineral density in the trunk skeleton, but maintained radius bone mineral density in 323 
amenorrheic athletes, is that long bones and the bones in the trunk respond differently to 324 
amenorrhea. Indeed, there are some indications in rat models that the responses to 325 
oestrogen on bone are site-specific [30], but this requires further investigation. 326 
 327 
Weight-bearing bones 328 
In the femur, bone CSA and the cortical width of the shaft were larger in both athlete groups 329 
than controls. This is consistent with previous observations [31] suggesting that the effects of 330 
loading are not attenuated in those with amenorrhea. Others have reported lower bone size 331 
and strength in amenorrheic compared to eumenorrheic athletes [32]. Part of the discrepancy 332 
may be related to the younger age of the athletes in previous studies. For instance, in one 333 
study the average age was 20 [33] and in another only 17 years [31], compared to the 26 years 334 
in our study, the age at which females have reached their maximum bone strength [34]. 335 
 336 
Although the tibia is a common stress fracture site in athletes, tibial diaphysis strength has 337 
been ignored in previous pQCT research involving amenorrheic and eumenorrheic athletes. 338 
In a monozygotic twin study it was found that regular physical activity resulted in an increase 339 
in BMD in the epiphysis of the tibia only [35]. This is similar to the larger BMD in the epiphysis, 340 
but not diaphysis, in the athletes than controls in our study and supports the notion that bone 341 
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adaptations to exercise may be site-specific [35]. Nevertheless, we found that bone size, 342 
strength and cortical bone area of the diaphysis was larger in athletes than controls, with no 343 
significant differences between amenorrheic and eumenorrheic athletes, except for the larger 344 
epiphyseal bone strength (indicated by total bone mass) over controls in eumenorrheic 345 
athletes only. This, similar to the observations in the femur, indicates that the effects of regular 346 
loading on bone [9, 36] are not attenuated by amenorrhea. 347 
 348 
Bone remodelling 349 
In both the radius and the tibia the endocortical circumference were larger in amenorrheic 350 
athletes than non-athletes, suggesting endocortical expansion (resorption) that could be 351 
attributable to their lack of oestrogen [37]. At the same time, both the radius and tibia had 352 
expanded. These findings are similar to that previously suggested by Mikkola et al [38], in that 353 
the effect of oestrogen is systemic with the tibia and radius being affected similarly. This effect 354 
also has some similarity to the decline in trabecular BMD [39] and increase in bone size [40] 355 
during pregnancy. This pregnancy-induced loss of BMD can be recovered during lactation 356 
when the child is weaned [39, 40] and if the underlying cause is similar, the expansion of the 357 
endocortical circumference in the amenorrheic athletes could most likely be recovered by 358 
normalisation of the menstrual cycle. In a study of monozygotic twins, hormone replacement 359 
therapy (HRT) was associated with larger cortical bone areas and smaller endocortical areas 360 
[38]. It is not known, however, if this would be effective in amenorrheic athletes as the 361 
duration of HRT in the twins study was on average 8 years. Although regular exercise was 362 
associated with a smaller endocortical area in monozygotic twins [35] it is unlikely that 363 
normalisation of the endocortical circumference in amenorrheic athletes can be realised by 364 
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increased loading, as both the unloaded radius and the loaded tibia exhibit this increase in 365 
endocortical circumference. 366 
 367 
Limitations 368 
It was not possible to include energy-deficient amenorrheic athletes in the current study, 369 
which may have offered further insights. However, this might equally be seen as a strength of 370 
our study because we were able to rule out the contribution of energy deficiency to our 371 
observations. Circulating levels of oestrogen were not measured which may have 372 
complemented the assessment of amenorrhea. However, oestrogen levels vary considerably 373 
during the menstrual cycle and diurnally, complicating distinction of eumonorrheic and 374 
amenorrheic athletes. Five of the athletes stated they were taking the oral contraceptive pill 375 
(OCP) for contraceptive reasons only. One AA who took OCP still suffered from amenorrhea 376 
and her bone parameters were all within the range of the group. The EA athletes all had 377 
regular cycles prior to using OCP and given these observations, we expect that OCP had no 378 
significant impact on our findings. 379 
 380 
Perspective 381 
The lower bone strength indicators in bones of the trunk but not the radius of amenorrheic 382 
athletes is not entirely explained by reduced loading, but rather suggests that the bone 383 
response to amenorrhea is site-specific. While the strength of weight bearing bones in the EA 384 
and AA are similar, the enlargement of the endocortical area, similar to that shown by Mikkola 385 
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et al [38], cannot be reversed by loading. We speculate that this can only be normalised by a 386 
return to a normal menstrual cycle. 387 
 388 
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 483 
 484 
Figure 1: A) Periosteal circumference (mm) for the radius diaphysis (RD) and tibia diaphysis 485 
(TD) adjusted for object length; B) Cortical Thickness (mm) for the radius diaphysis (RD) and 486 
tibia diaphysis (TD) adjusted for object length; C) Cortical Area (mm2) for the radius diaphysis 487 
(RD) and the tibia diaphysis (TD) adjusted for object length; D) Endocortical Circumference 488 
(mm) for the radius diaphysis (RD) and the tibia diaphysis (TD) adjusted for object length. C: 489 
controls, EA: eumenorrheic athletes, AA: amenorrheic athletes. a Significantly different from 490 
controls.  491 
 492 
 493 
 494 
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495 
FIGURE LEGEND 496 
Figure 2: A Schematic diagram to show the difference between groups in the endocortical 497 
circumference (EC) and Periosteal Circumference (PeriC) of the tibia. AA have a significantly 498 
greater circumferences’ than both EA and controls with no difference between EA and 499 
controls. *=significantly different to controls; §=significantly different to EA. % increase is 500 
shown as an average of tibia and radius increase compared to controls.501 
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 502 
Table 1. Characteristics of controls (C), and eumenorrheic (EA) and amenorrheic athletes (AA).  503 
 
C 
N=15 
EA 
N=15 
AA 
N=14 
P VALUE 
C VS. AA 
P VALUE 
C VS. EA 
P VALUE 
AA VS. EA 
Age (Years) 26.8±0.9 27.6±2.1 26.4±0.8 0.863 0.714 0.594 
Height (m) 1.66±0.17 1.66±0.02 1.64±0.02 0.590 0.862 0.479 
Mass (kg) 59.6±1.5 54.5±1.3 49.6±1.6 <0.0005 0.037 0.029 
BMI (kg·m-2) 21.7±0.6 19.8±0.4 18.3±0.4 <0.0005 0.009 0.045 
Lean mass (kg) 39.0±1.6 44.5±1.1 42.0±1.2 0.112 0.015 0.215 
Fat mass (kg) 18.5±1.5 8.1±0.7 5.3±0.6 <0.0005 <0.0005 0.054 
Body fat mass (%) 30.6±2.1 14.9±1.2 10.7±1.0 <0.0005 <0.0005 0.065 
Lean mass (%) 65.4±2.2 82.4±1.2 86.8±1.1 <0.0005 <0.0005 0.059 
AGP (%) N/A 86.9±1.0
 
86.6±1.2
 
N/A N/A 0.890 
Age of menarche  (years) 13.0±0.34 14.1±0.35 14.9±0.54 0.01 0.051 0.275 
Data are presented as mean ± SEM. AGP: Age-graded performance. 504 
 505 
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Table 2. Muscle size and strength and femur size in controls (C), eumenorrheic athletes (EA) and amenorrheic athletes (AA) as determined with 506 
MRI. 507 
 508 
 509 
 510 
 511 
 512 
 513 
 514 
 515 
 516 
 517 
 518 
 519 
Data are presented as mean ± SEM. P-values reflect those related to the data adjusted for Femur length in leg measures and radius length for 520 
forearm measures. 521 
  522 
 
C EA AA P VALUE 
 n=15 n=15 n=14 C vs. AA C vs. EA AA vs. EA 
Forearm Muscle CSA (mm2) 2617±93 2637±94 2516±101 0.555 0.876 0.458 
Lower Leg Muscle CSA (mm
2
) 6457±221 7002±193 7099±242 0.225 0.944 0.198 
Calf Volume (cm³) 1316±70 1317±74 1325±86 0.670 0.556 0.884 
Quadriceps Volume (cm³) 1239±89 1469±92 1461±80 0.146 0.157 0.951 
Quadriceps Strength (Nm) 171±6 164±7 163±10 0.314 0.304 0.992 
Normalised Force (Nm.cm¯³) 0.141±0.008 0.115±0.007 0.117±0.007 0.045 0.035 0.921 
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Table 3. Bone mineral density as obtained with DXA data for controls (C) and eummenhoreic (EA) and ammenorheic athletes (AA). 523 
 C EA AA P VALUE (AD FOR BODY HEIGHT) 
 n=15 n =15 n=14 C vs. AA C vs. EA AA vs. EA 
Total (g·cm-2) 1.17±0.02 1.19±0.01 1.13±0.03 0.318 0.365 0.064 
Arms (g·cm-2) 0.82±0.01 0.83±0.01 0.81±0.03 0.715 0.575 0.364 
Average Hip (g·cm-2) 1.06±0.04 1.12±0.03 1.02±0.04 0.435 0.302 0.078 
Trunk (g·cm-2) 0.91±0.03 0.91±0.02 0.82±0.02 0.002 0.909 0.003 
Ribs (g·cm-2) 0.68±0.02 0.65±0.02 0.62±0.01 0.005 0.100 0.198 
Spine L1-4 (g·cm-2) 1.19±0.03 1.16±0.03 1.04±0.04 0.004 0.585 0.015 
Pelvis (g·cm-2) 1.11±0.01 1.14±0.02 0.99±0.03 0.004 0.568 0.001 
Legs (g·cm-2) 1.25±0.03 1.33±0.02  1.26±0.03 0.555 0.032 0.122 
 524 
Data are presented as mean ± SEM. 525 
  526 
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Table 4. Hip and femur structural characteristics for controls (C) and eummenhoreic (EA) and ammenorheic athletes (AA). 527 
 
        C EA AA p value (ad for FL) 
  
n=15 
 
n=15 
 
n=14 
 
C vs. AA 
 
C vs. EA 
 
AA vs. EA 
Cortical width shaft (mm) 3.73±0.33 5.68±0.41 4.89±0.43 0.034 0.001 0.182 
Cortical width neck (mm) 6.16±0.59 7.20±0.50 6.89±0.40 0.411 0.198 0.642 
CSA femoral neck (mm2) 146±7.9 158±4.7 146±5.7 0.698 0.255 0.134 
Strength Index (BSI) 1.69±0.10 1.81±0.07 1.89±0.11 0.161 0.398 0.570 
CSMI (mm4) 9645±601 9840±676 8645±524 0.056 0.847 0.086 
Femur CSA (cm²) 10.5±1.1 16.4±0.9  15.9±2.0  0.013 0.005 0.788 
Femur Volume (cm³) 56.6±6.2 88.4±5.1  85.5±10.8  0.012 0.005 0.769 
 528 
Data are presented as mean ± SEM. Cross-sectional moment of inertia (CSMI), cross-sectional area (CSA) of the femur neck. P values displayed 529 
for data adjusted for femur length (FL). 530 
  531 
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Table 5. Peripheral quantitative computer tomography (pQCT) data for the Radius epiphysis (RE, 4%) and Radius diaphysis (RD, 60%) in controls 532 
(C), and eumenorrheic (EA) and amenorrheic athletes (AA). 533 
 534 
 535 
 536 
 537 
 538 
 539 
 540 
 541 
 542 
 543 
 544 
RE: Radius epiphysis; RD: Radius diaphysis; vBMDct (mg·mm-³): Cortical bone mineral density; vBMDtb (mgmm-³): Trabecular bone mineral 545 
density; Artot (mm²); Arct (mm²): Cortical Area: EcC (mm): Endochondral circumference; Iy and Ix, (mm4): moment of inertia indicating bone’s 546 
Stiffness in bending perpendicular to line of flexion/extension, in line with flexion/extension and torsion respectively. Data are presented as mean 547 
± SEM. 548 
 
C EA AA P VALUE (AD FOR RADIUS LENGTH) 
 n=15 n=15 n=14 C vs. AA C vs. EA AA vs. EA 
RE Ar.tot (mm2) 319±14 367±14 365±15 0.035 0.023 0.931 
RE vBMC.tot (mg.mm-¹) 101±4 109±4 102±6 0.861 0.220 0.304 
RE vBMD.tb (mg.mm-³) 186±9 197±11 197±15 0.604 0.576 0.984 
RD Ar.tot (mm2) 102±4 111±3 112±4 0.034 0.045 0.839 
RD vBMC.tot (mg.mm-1) 93.0±4.0 103.2±4.0 98.9±4.3 0.997 0.336 0.529 
RD vBMDct (mg.mm-3) 1132±14 1144±8 1142±11 0.819 0.721 0.907 
RD Iy (mm
4
) 138±7 158±7 156±7 0.067 0.032 0.801 
RD Ix (mm
4
) 135±8 149±8 151±8 0.165 0.190 0.896 
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Table 6. Peripheral quantitative computer tomography (pQCT) data for the Tibia epiphysis (TE, 4%) and Tibia diaphysis (TD, 66%) in controls (C), 549 
and eumenorrheic (EA) and amenorrheic athletes (AA). 550 
 551 
 
C EA AA P VALUE (AD FOR TIBIA LENTGH) 
 n=15 n=15 n=14 C vs. AA C vs. EA AA vs. EA 
TE vBMC.tot (mg·mm-¹) 296±11 337±11 324±12 0.147 0.012 0.858 
TE vBMD.tb (mg·mm-³) 232±12 263±10 265±10 0.024 0.028 0.091 
TE Ar.tot (mm²) 977±36 1067±32 1056±34 0.032 0.032 0.437 
TD Ar.tot (mm2) 436±17 500±11 522±22 <0.0005 0.004 0.213 
TD vBMC.tot (mg·mm-¹) 312±9 390±8 364±10 0.006 <0.0005 0.153 
TD vBMD.ct (mg·mm-3) 1127±7 1122±7 1112±8 0.02 <0.0005 0.280 
TD Ix (mm
4
) 1288±58 1580±60 1696±63 <0.0005 0.001 0.237 
TD Iy (mm
4
) 863±41 1077±43 1071±45 0.004 <0.0005 0.599 
 552 
TE: Tibia epiphysis; TD: Tibia diaphysis; vBMDct (mg·mm-³): Cortical bone mineral density; vBMDtb (mgmm-³): Trabecular bone mineral density; 553 
Artot (mm²); Arct (mm²): Cortical Area: EcC (mm): Endochondral circumference; Iy and Ix, (mm4): moment of inertia indicating bone’s stiffness 554 
in bending perpendicular to line of flexion/extension, in line with flexion/extension and torsion respectively. Data are presented as mean ± SEM. 555 
 556 
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